bluebird (BLUE) Reports Updated Data on Lenti-D Gene Therapy – Yahoo Finance
bluebird (BLUE) Reports Updated Data on Lenti-D Gene Therapy Yahoo Financebluebird bio (BLUE) announces updated results from phase II/III Starbeam study of its Lenti-D gene therapy in boys aged 17 years or below with CALD.